Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
grade D 0.9573 -9.69% -0.10
AYTU closed up 15.22 percent on Tuesday, January 15, 2019, on 4.18 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical AYTU trend table...

Date Alert Name Type % Chg
Jan 15 Crossed Above 50 DMA Bullish -9.69%
Jan 15 MACD Bullish Centerline Cross Bullish -9.69%
Jan 15 Pocket Pivot Bullish Swing Setup -9.69%
Jan 15 Volume Surge Other -9.69%
Jan 15 Wide Range Bar Range Expansion -9.69%
Jan 15 Wide Bands Range Expansion -9.69%
Jan 15 Above Upper BB Strength -9.69%
Jan 15 Upper Bollinger Band Touch Strength -9.69%
Jan 14 Fell Below 50 DMA Bearish 4.05%
Jan 14 Wide Bands Range Expansion 4.05%

Older signals for AYTU ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
Is AYTU a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 85.2
52 Week Low 0.68
Average Volume 627,256
200-Day Moving Average 4.5228
50-Day Moving Average 0.93
20-Day Moving Average 0.8601
10-Day Moving Average 0.918
Average True Range 0.1021
ADX 19.25
+DI 35.9231
-DI 12.4956
Chandelier Exit (Long, 3 ATRs ) 0.8837
Chandelier Exit (Short, 3 ATRs ) 0.9863
Upper Bollinger Band 1.0369
Lower Bollinger Band 0.6833
Percent B (%b) 1.07
BandWidth 41.111499
MACD Line 0.0067
MACD Signal Line -0.0265
MACD Histogram 0.0332
Fundamentals Value
Market Cap 4.26 Million
Num Shares 4.02 Million
EPS -48.30
Price-to-Earnings (P/E) Ratio -0.02
Price-to-Sales 4.58
Price-to-Book 0.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.39
Resistance 3 (R3) 1.40 1.29 1.34
Resistance 2 (R2) 1.29 1.21 1.29 1.32
Resistance 1 (R1) 1.18 1.16 1.13 1.17 1.30
Pivot Point 1.07 1.07 1.05 1.07 1.07
Support 1 (S1) 0.96 0.99 0.91 0.95 0.82
Support 2 (S2) 0.85 0.94 0.85 0.80
Support 3 (S3) 0.74 0.85 0.79
Support 4 (S4) 0.73